Immediate Impact
27 standout
Citing Papers
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease
2024 Standout
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
2023 Standout
Works of Marek Tomala being referenced
Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study
2017
Urinary 11‐Dehydro‐Thromboxane B 2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marek Tomala | 332 | 130 | 122 | 30 | 391 | |
| Maciej Bagieński | 336 | 142 | 121 | 26 | 374 | |
| Robert Sobczyński | 372 | 176 | 174 | 40 | 456 | |
| Maciej Stąpór | 308 | 162 | 133 | 33 | 347 | |
| Zhi‐Liang Zuo | 336 | 141 | 90 | 26 | 430 | |
| Masahiro Seo | 278 | 63 | 93 | 58 | 399 | |
| Nicholas D. Gollop | 230 | 57 | 164 | 23 | 436 | |
| Lars Peter Riber | 305 | 50 | 65 | 54 | 420 | |
| Jingping Sun | 289 | 50 | 45 | 20 | 402 | |
| Vincenzo Zaccone | 121 | 81 | 65 | 39 | 443 | |
| Barbara Lubiszewska | 290 | 176 | 115 | 31 | 405 |
All Works
Loading papers...